Deleterious effect of formycin A on tumor islet cells

Biochem Mol Med. 1995 Apr;54(2):138-41. doi: 10.1006/bmme.1995.1020.

Abstract

The adenosine analogue formycin A was recently introduced as a potent insulin secretagogue in normal pancreatic islet cells. In the present study, formycin A was found to inhibit insulin release and to exert a cytotoxic effect in tumor islet cells of the RINm5F line. The latter effect was concentration-related in the 10-100 microM range of formycin A concentrations, not rapidly reversed, and not reproduced by adenosine. This study thus reveals that formycin A may display cytotoxic potential in the same range of concentrations in which it causes a progressive increase of glucose-stimulated insulin secretion in normal pancreatic islets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Islet Cell / drug therapy*
  • Adenosine / analogs & derivatives
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Formycins / pharmacology*
  • Insulin / chemistry
  • Insulin / metabolism
  • Insulin Secretion
  • Pancreatic Neoplasms / chemistry
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology*
  • Proteins / chemistry
  • Proteins / drug effects
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Formycins
  • Insulin
  • Proteins
  • formycin
  • Adenosine